Developer docs
API playgroundTry for free, no card

Search company profiles

FCI

Full company profile

uuid0007lxo

Namestring
FCI
Legal namestring
FCI S.A.S.
Websiteurl
fci.fr
Company typeenum
Private
Founded yearint
1984
Descriptiontext

FCI S.A.S. is a French medical device manufacturer founded in 1984 (originally as France Chirurgie Instrumentation) that designs, develops, and distributes ophthalmic surgical devices and instruments. The company's core expertise lies in biomaterials, particularly silicone-based implants and surgical instruments, organized across seven therapeutic areas: oculoplastics, dry eye, retina, cataract, glaucoma, surgical instruments, and veterinary ophthalmology. Its proprietary product portfolio includes LacriJet (preloaded monocanaliculo-nasal intubation), Painless Plug (preloaded meatal occlusion device for dry eye), Precivia (intravitreal injection guide pre-calibrated at 3.5mm and 28°), Implant de Paul (soft silicone glaucoma implant), Ahmed glaucoma valves, and directional laser fibers. FCI also distributes third-party brands including MORCHER (IOLs and capsular rings), Katalyst Surgical (STIFF vitrectomy instruments), PSI and SHARPOINT single-use cannulas and knives, and FIMCO hand instruments, plus complete surgical instrument boxes for cataract, retina, glaucoma, strabismus, eyelid, DCR, and lacrimal procedures.

FCI operates as a wholly-owned subsidiary of ZEISS (Carl Zeiss AG) within the ZEISS Medical Technology segment, with international reach through wholly-owned subsidiaries FCI Worldwide (international markets) and FCI Ophthalmics (US and Canada). The company generates revenue through direct sales of proprietary and distributed medical devices to ophthalmic surgeons, hospitals, and surgical centers via a quote-based B2B model, complemented by the FCI School training platform and participation in industry congresses such as SFO. Distribution is supported by certifications including ISO 13485:2016, MDSAP, CE marking under GMED CE N°0459, and a TCP certificate for Taiwan market access. The head office is at 20-22 rue Louis Armand in Paris with 51-100 employees.

Short descriptiontext

FCI S.A.S., a wholly-owned ZEISS subsidiary, designs and distributes ophthalmic surgical medical devices — including implants, intubation systems, and instruments — for eye surgeons, hospitals, and clinics across cataract, glaucoma, retina, dry eye, and oculoplastics.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ophthalmic medical devices, surgical instruments, cataract surgery products, glaucoma implants, vitreoretinal surgery
Industry3 codes
1Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics)
CodeHLAHAJAHPrimaryYes
2Oculoplastics & Lacrimal Surgical Devices (Ptosis/Orbital Tools, DCR/Lacrimal Stents, Facial Implants)
CodeHLAHAJALPrimaryNo
3Vitreoretinal Surgical Devices (Vitrectomy Systems, Endolaser, Illumination, Tamponades)
CodeHLAHAJAJPrimaryNo
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Ophthalmic Goods Manufacturing339115
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Ophthalmic Goods3851
Product category
Ophthalmic Medical Devices
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Medical device sales
TypeOne Time License
Description

FCI generates revenue through the sale of ophthalmic surgical medical devices and instruments including implants, single-use devices, and reusable surgical instruments to hospitals, clinics, and ophthalmic surgeons.

fci.fr
2Distributed products
TypeOne Time License
Description

FCI distributes third-party ophthalmic brands including MORCHER, PSI, SHARPOINT, Katalyst Surgical instruments, and others, generating revenue through distribution margins.

fci.fr
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Pricing details1 tier
1Medical devices and surgical instruments
ModelOtherBilling cadenceMulti-year contract
Notes

Products are available via quote request system. No public pricing listed on website.

fci.fr
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

FCI S.A.S. manufactures, designs, and distributes ophthalmic surgical medical devices and instruments for eye surgery. The portfolio spans seven therapeutic areas — oculoplastics (lacrimal pathways, eyelids, orbit), dry eye (meatal plugs), retina (scleral implants, laser fibers, silicone oil), cataract (intraocular lenses, capsular rings, knives, cannulas), glaucoma (valves, implants), surgical instruments, and veterinary ophthalmology. The company also distributes third-party ophthalmic brands including MORCHER, Katalyst Surgical, PSI, and SHARPOINT.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Over 700,000 cataract surgeries performed annually in France alone using these types of devices
Product overview1 text field

FCI S.A.S. is a French medical device manufacturer founded in 1984, specializing in biomaterials for ophthalmic surgery. The company operates as a ZEISS Company and offers a comprehensive portfolio organized across seven main therapeutic areas: Oculoplastics (lacrimal pathway surgery, eyelid, orbit), Dry Eye (meatal plugs, punctum plugs), Retina (vitreoretinal surgery, scleral implants, laser fibers), Cataract (IOLs, capsular rings, surgical knives), Glaucoma (valves, implants), Instruments, and Veterinary ophthalmology. Key branded products include LacriJet® (preloaded monocanaliculo-nasal intubation), Painless Plug® (meatal occlusion), Precivia® (intravitreal injection guide), Paul Implant® (glaucoma), and OCUBLU-TRY (trypan blue). FCI distributes products from MORCHER (capsular rings, IOLs) and Katalyst Surgical (STIFF instruments), while manufacturing its own instrument lines under FCI branding. The company also offers complete surgical instrument boxes for various procedures (Cataract, Retina, Glaucoma, Strabismus, Eyelid, Enucleation/Evisceration, DCR, Lacrimal Pathways). Products are primarily distributed in France through the fci.fr portal with international operations via FCI Worldwide and FCI Ophthalmics (US/Canada).

Product and service16 records
1LacriJet®
CategoryOculoplastics / Lacrimal Intubation
Description

Preloaded monocanaliculo-nasal intubation device for treating lacrimal pathway obstructions; designed for ophthalmic surgeons performing lacrimal duct surgery.

2Painless Plug®
CategoryDry Eye / Punctal Occlusion
Description

Preloaded meatal plug for occlusion of lacrimal points in the treatment of dry eye syndrome; adapts to the ampulla of the lacrimal point without requiring prior meatal dilation.

3Precivia®
CategoryRetina / Surgical Accessories
Description

Intravitreal injection assistant device that systematically pre-calibrates injections at 3.5mm from the limbus with a fixed 28° angle and secured injection depth; for retinal specialists performing intravitreal injections.

4Implant de Paul®
CategoryGlaucoma Implants
Description

Soft silicone glaucoma implant for the surgical treatment of refractory glaucoma; for ophthalmic surgeons managing complex glaucoma cases.

5Ahmed™ Glaucoma Valves
CategoryGlaucoma Drainage Devices
Description

Glaucoma drainage devices implanted to reduce intraocular pressure in refractory glaucoma cases.

6Scleral Implants (Bands, Rails, Wheels, Sponges)
CategoryRetina / Scleral Buckling
Description

Scleral implants in silicone and PTFEe materials for external approach retinal detachment surgery, including bands (Ducournau, Morin), rails, wheels, and sponges in various configurations.

7Silicone Oil and PFCL
CategoryRetina / Vitreoretinal Tamponade
Description

Vitreoretinal tamponade products including purified silicone oil and perfluorocarbon liquids for temporary or prolonged retinal tamponade.

8Directional Laser Fibers
CategoryRetina / Laser Surgical Accessories
Description

Directional laser fibers with slider mechanism for vitreoretinal laser photocoagulation procedures.

9Intubation Products (Monoka®, Mini-Monoka®, Masterka®, Ritleng®+)
CategoryOculoplastics / Lacrimal Intubation
Description

Complete range of lacrimal intubation devices including Monoka Fayet-Bernard (Ritleng technique), Mini-Monoka for canalicular trauma, Masterka monocanalicular-nasal intubation, and Ritleng+ bicanalicular-nasal intubation, available in silicone and PVP-coated versions.

10OCUBLU-TRY (Trypan Blue 0.06%)
CategoryCataract Surgery / Ophthalmic Dyes
Description

Trypan blue 0.06% dye solution for staining the anterior capsule during cataract surgery, enhancing visualization during capsulorhexis.

11Ophtacath®
CategoryOculoplastics / Lacrimal Surgery
Description

Balloon catheter for dilating the nasolacrimal canal in dacryocystoplasty procedures.

12Clou-Trou® PVP
CategoryDry Eye / Punctal Plugs
Description

Perforated punctum plugs in silicone with PVP coating for treating epiphora caused by punctal atresia, available in standard and mini versions.

13Meatal Plugs
CategoryDry Eye / Punctal Occlusion
Description

Punctal occlusion devices for dry eye treatment including ready-to-use meatal plugs in 5 sizes (Micro, Mini, Small, Regular, Large) with inclined collar design.

14STIFF Forceps and Scissors (Katalyst)
CategoryRetina / Vitrectomy Instruments
Description

STIFF reinforced single-use forceps and scissors for retinal surgery including Tano, Awh, Honey Badger, Super Grip, End-Grasping, and Maculorhexis models, featuring a STIFF 19Ga 100% retractable tube for enhanced rigidity in 23Ga, 25Ga, and 27Ga sizes.

15Surgical Instrument Boxes
CategoryOphthalmic Surgical Instruments
Description

Complete surgical instrument sets for ophthalmic procedures: Cataract Phaco/Micro-incision box, Retina box, Glaucoma box, Strabismus box, Chalazion box, Eyelid surgery box, Enucleation/Evisceration box, Dacryocystorhinostomy box, and Lacrimal Pathways box.

16Cataract Products (Intraocular Lenses, Capsular Rings, Knives)
CategoryCataract Surgery
Description

Complete cataract surgery portfolio including MORCHER capsular tension rings and rings of Cionni, aniridic implants, intraocular lenses, single-use surgical knives, single-use cannulas, and Kitaro Kits training tools.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeOthers
Description

FCI is a subsidiary of ZEISS (Carl Zeiss AG). The company operates as part of the ZEISS Medical Technology segment, leveraging ZEISS's global brand and distribution infrastructure.

Strategic tierCoreTypeTechnology or Integration
Description

FCI distributes Katalyst Surgical's range of STIFF reinforced vitrectomy forceps and scissors (25Ga and 27Ga). The partnership brings advanced micro-incision surgical instruments to FCI's product portfolio.

Strategic tierMajorTypeTechnology or Integration
Description

FCI distributes MORCHER brand intra-ocular lenses, capsular tension rings, and aniridia implants for cataract surgery.

4PSI (Professional Surgical Instruments)
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

FCI distributes PSI brand single-use ophthalmic canules including retrobulbar, peribulbar, Rycroft anterior chamber, aspiration, Charleux, cystitomes, capsule polishers, and irrigation/aspiration canulae.

fci.fr
5SHARPOINT
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

FCI distributes SHARPOINT brand surgical products for ophthalmic procedures.

fci.fr
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global ophthalmic medical device leader with full portfolios in cataract IOLs, vitreoretinal surgery platforms (Constellation), and surgical instruments. Comparable to FCI as the dominant broad-line incumbent across virtually every category FCI competes in and with whom FCI instruments are validated for compatibility.

2Asico
TypeDirect peer
Description

US manufacturer of ophthalmic microsurgical instruments including forceps, scissors, and speculums used in cataract and vitreoretinal surgery. Comparable to FCI on reusable and single-use surgical instrument portfolios sold directly to ophthalmic surgeons.

TypeDirect peer
Description

German manufacturer of ophthalmic surgical instruments, devices, and consumables including vitreoretinal and glaucoma equipment. Comparable to FCI as a European specialist serving cataract, vitreoretinal, and glaucoma surgeons with proprietary and distributed instruments.

TypeDirect peer
Description

France-based specialist in ophthalmic surgical instruments, knives, and micro-surgical devices. Highly comparable as a French-headquartered, niche-focused ophthalmic surgical instrument and device manufacturer with overlapping categories in cataract, cornea, and oculoplastics.

TypeDirect peer
Description

US-based manufacturer of ophthalmic surgical instruments including forceps, scissors, needle holders, and speculums. Comparable to FCI on reusable stainless-steel ophthalmic instruments and global distribution to cataract and vitreoretinal surgeons.

TypeEmerging player
Description

US ophthalmic device company specializing in glaucoma drainage devices (Ahmed, Baerveldt) and surgical implants. Comparable to FCI in the glaucoma implant category where FCI distributes Ahmed valves and its own Implant de Paul.

TypeDirect peer
Description

US ophthalmic surgical products company offering instruments, IOLs, and consumables used in cataract, glaucoma, and oculoplastic surgery. Comparable to FCI as a multi-category ophthalmic surgical device and instrument supplier to hospital and ambulatory surgery centers.

TypeDirect peer
Description

US-based manufacturer of single-use ophthalmic surgical instruments, blades, and cannulas. Comparable to FCI on single-use ophthalmic disposables, microsurgical instruments, and hospital-direct sales motion across cataract and vitreoretinal procedures.

TypeDirect peer
Description

US-based ophthalmic surgical device company producing micro-incision instruments and specialty devices for cataract, vitreoretinal, and glaucoma surgery. Comparable to FCI on micro-incision instrumentation and direct-to-surgeon specialty ophthalmic distribution.

TypeDirect peer
Description

Dutch ophthalmic device company specializing in vitreoretinal surgery systems, instruments, and tamponades. Directly comparable as a vitreoretinal surgical devices specialist and a fellow ZEISS Medical Technology portfolio company following acquisition.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

FCI

Ophthalmic Medical Devicesfci.fr

FCI S.A.S., a wholly-owned ZEISS subsidiary, designs and distributes ophthalmic surgical medical devices — including implants, intubation systems, and instruments — for eye surgeons, hospitals, and clinics across cataract, glaucoma, retina, dry eye, and oculoplastics.

What FCI does

FCI S.A.S. is a French medical device manufacturer founded in 1984 (originally as France Chirurgie Instrumentation) that designs, develops, and distributes ophthalmic surgical devices and instruments. The company's core expertise lies in biomaterials, particularly silicone-based implants and surgical instruments, organized across seven therapeutic areas: oculoplastics, dry eye, retina, cataract, glaucoma, surgical instruments, and veterinary ophthalmology. Its proprietary product portfolio includes LacriJet (preloaded monocanaliculo-nasal intubation), Painless Plug (preloaded meatal occlusion device for dry eye), Precivia (intravitreal injection guide pre-calibrated at 3.5mm and 28°), Implant de Paul (soft silicone glaucoma implant), Ahmed glaucoma valves, and directional laser fibers. FCI also distributes third-party brands including MORCHER (IOLs and capsular rings), Katalyst Surgical (STIFF vitrectomy instruments), PSI and SHARPOINT single-use cannulas and knives, and FIMCO hand instruments, plus complete surgical instrument boxes for cataract, retina, glaucoma, strabismus, eyelid, DCR, and lacrimal procedures.

FCI operates as a wholly-owned subsidiary of ZEISS (Carl Zeiss AG) within the ZEISS Medical Technology segment, with international reach through wholly-owned subsidiaries FCI Worldwide (international markets) and FCI Ophthalmics (US and Canada). The company generates revenue through direct sales of proprietary and distributed medical devices to ophthalmic surgeons, hospitals, and surgical centers via a quote-based B2B model, complemented by the FCI School training platform and participation in industry congresses such as SFO. Distribution is supported by certifications including ISO 13485:2016, MDSAP, CE marking under GMED CE N°0459, and a TCP certificate for Taiwan market access. The head office is at 20-22 rue Louis Armand in Paris with 51-100 employees.

FCI firmographics

Firmographics
Name
FCI
Legal name
FCI S.A.S.
Website
https://fci.fr
Company type
Private
Founded year
1984
Operating status
Operating
Headcount range
51–100 employees
Short description
FCI S.A.S., a wholly-owned ZEISS subsidiary, designs and distributes ophthalmic surgical medical devices — including implants, intubation systems, and instruments — for eye surgeons, hospitals, and clinics across cataract, glaucoma, retina, dry eye, and oculoplastics.
Ownership category
akta.pro rank

FCI industry classification

Industry
Product category
Ophthalmic Medical Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112), Ophthalmic Goods Manufacturing (339115)
SIC
Surgical & Medical Instruments & Apparatus (3841), Ophthalmic Goods (3851)
akta.pro primary industry
Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics) (HLAHAJAH)
akta.pro secondary industries
Oculoplastics & Lacrimal Surgical Devices (Ptosis/Orbital Tools, DCR/Lacrimal Stents, Facial Implants) (HLAHAJAL), Vitreoretinal Surgical Devices (Vitrectomy Systems, Endolaser, Illumination, Tamponades) (HLAHAJAJ)

Keywords

  • Ophthalmic medical devices
  • Surgical instruments
  • Cataract surgery products
  • Glaucoma implants
  • Vitreoretinal surgery

Where FCI is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices1 record

Markets served

FCI business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Medical device sales: FCI generates revenue through the sale of ophthalmic surgical medical devices and instruments including implants, single-use devices, and reusable surgical instruments to hospitals, clinics, and ophthalmic surgeons.
  2. Distributed products: FCI distributes third-party ophthalmic brands including MORCHER, PSI, SHARPOINT, Katalyst Surgical instruments, and others, generating revenue through distribution margins.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractMedical devices and surgical instruments

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

FCI product offering

Product offering

Core offering

FCI S.A.S. manufactures, designs, and distributes ophthalmic surgical medical devices and instruments for eye surgery. The portfolio spans seven therapeutic areas — oculoplastics (lacrimal pathways, eyelids, orbit), dry eye (meatal plugs), retina (scleral implants, laser fibers, silicone oil), cataract (intraocular lenses, capsular rings, knives, cannulas), glaucoma (valves, implants), surgical instruments, and veterinary ophthalmology. The company also distributes third-party ophthalmic brands including MORCHER, Katalyst Surgical, PSI, and SHARPOINT.

Product overview

FCI S.A.S. is a French medical device manufacturer founded in 1984, specializing in biomaterials for ophthalmic surgery. The company operates as a ZEISS Company and offers a comprehensive portfolio organized across seven main therapeutic areas: Oculoplastics (lacrimal pathway surgery, eyelid, orbit), Dry Eye (meatal plugs, punctum plugs), Retina (vitreoretinal surgery, scleral implants, laser fibers), Cataract (IOLs, capsular rings, surgical knives), Glaucoma (valves, implants), Instruments, and Veterinary ophthalmology. Key branded products include LacriJet® (preloaded monocanaliculo-nasal intubation), Painless Plug® (meatal occlusion), Precivia® (intravitreal injection guide), Paul Implant® (glaucoma), and OCUBLU-TRY (trypan blue). FCI distributes products from MORCHER (capsular rings, IOLs) and Katalyst Surgical (STIFF instruments), while manufacturing its own instrument lines under FCI branding. The company also offers complete surgical instrument boxes for various procedures (Cataract, Retina, Glaucoma, Strabismus, Eyelid, Enucleation/Evisceration, DCR, Lacrimal Pathways). Products are primarily distributed in France through the fci.fr portal with international operations via FCI Worldwide and FCI Ophthalmics (US/Canada).

Differentiator

Problem solved

Functional benefit

Products and services

  • LacriJet® Preloaded monocanaliculo-nasal intubation device for treating lacrimal pathway obstructions; designed for ophthalmic surgeons performing lacrimal duct surgery.
  • Painless Plug® Preloaded meatal plug for occlusion of lacrimal points in the treatment of dry eye syndrome; adapts to the ampulla of the lacrimal point without requiring prior meatal dilation.
  • Precivia® Intravitreal injection assistant device that systematically pre-calibrates injections at 3.5mm from the limbus with a fixed 28° angle and secured injection depth; for retinal specialists performing intravitreal injections.
  • Implant de Paul® Soft silicone glaucoma implant for the surgical treatment of refractory glaucoma; for ophthalmic surgeons managing complex glaucoma cases.
  • Ahmed™ Glaucoma Valves Glaucoma drainage devices implanted to reduce intraocular pressure in refractory glaucoma cases.
  • Scleral Implants (Bands, Rails, Wheels, Sponges) Scleral implants in silicone and PTFEe materials for external approach retinal detachment surgery, including bands (Ducournau, Morin), rails, wheels, and sponges in various configurations.
  • Silicone Oil and PFCL Vitreoretinal tamponade products including purified silicone oil and perfluorocarbon liquids for temporary or prolonged retinal tamponade.
  • Directional Laser Fibers Directional laser fibers with slider mechanism for vitreoretinal laser photocoagulation procedures.
  • Intubation Products (Monoka®, Mini-Monoka®, Masterka®, Ritleng®+) Complete range of lacrimal intubation devices including Monoka Fayet-Bernard (Ritleng technique), Mini-Monoka for canalicular trauma, Masterka monocanalicular-nasal intubation, and Ritleng+ bicanalicular-nasal intubation, available in silicone and PVP-coated versions.
  • OCUBLU-TRY (Trypan Blue 0.06%) Trypan blue 0.06% dye solution for staining the anterior capsule during cataract surgery, enhancing visualization during capsulorhexis.
  • Ophtacath® Balloon catheter for dilating the nasolacrimal canal in dacryocystoplasty procedures.
  • Clou-Trou® PVP Perforated punctum plugs in silicone with PVP coating for treating epiphora caused by punctal atresia, available in standard and mini versions.
  • Meatal Plugs Punctal occlusion devices for dry eye treatment including ready-to-use meatal plugs in 5 sizes (Micro, Mini, Small, Regular, Large) with inclined collar design.
  • STIFF Forceps and Scissors (Katalyst) STIFF reinforced single-use forceps and scissors for retinal surgery including Tano, Awh, Honey Badger, Super Grip, End-Grasping, and Maculorhexis models, featuring a STIFF 19Ga 100% retractable tube for enhanced rigidity in 23Ga, 25Ga, and 27Ga sizes.
  • Surgical Instrument Boxes Complete surgical instrument sets for ophthalmic procedures: Cataract Phaco/Micro-incision box, Retina box, Glaucoma box, Strabismus box, Chalazion box, Eyelid surgery box, Enucleation/Evisceration box, Dacryocystorhinostomy box, and Lacrimal Pathways box.
  • Cataract Products (Intraocular Lenses, Capsular Rings, Knives) Complete cataract surgery portfolio including MORCHER capsular tension rings and rings of Cionni, aniridic implants, intraocular lenses, single-use surgical knives, single-use cannulas, and Kitaro Kits training tools.

Quantifiable outcome

  • Over 700,000 cataract surgeries performed annually in France alone using these types of devices

Companies that use FCI

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

FCI technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

Feature8 records

FCI partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core, major and minor.

  • ZEISScoreOthersFCI is a subsidiary of ZEISS (Carl Zeiss AG). The company operates as part of the ZEISS Medical Technology segment, leveraging ZEISS's global brand and distribution infrastructure.
  • Katalyst SurgicalcoreTechnology or IntegrationFCI distributes Katalyst Surgical's range of STIFF reinforced vitrectomy forceps and scissors (25Ga and 27Ga). The partnership brings advanced micro-incision surgical instruments to FCI's product portfolio.
  • MORCHERmajorTechnology or IntegrationFCI distributes MORCHER brand intra-ocular lenses, capsular tension rings, and aniridia implants for cataract surgery.
  • PSI (Professional Surgical Instruments)minorChannel Partner/ Reseller/ DistributorFCI distributes PSI brand single-use ophthalmic canules including retrobulbar, peribulbar, Rycroft anterior chamber, aspiration, Charleux, cystitomes, capsule polishers, and irrigation/aspiration canulae.
  • SHARPOINTminorChannel Partner/ Reseller/ DistributorFCI distributes SHARPOINT brand surgical products for ophthalmic procedures.

Scale indicators2 records

Recent moves7 records

Expansion highlights5 records

FCI competitors and assessment

Company assessment

Broad incumbents

  • Alcon: Global ophthalmic medical device leader with full portfolios in cataract IOLs, vitreoretinal surgery platforms (Constellation), and surgical instruments. Comparable to FCI as the dominant broad-line incumbent across virtually every category FCI competes in and with whom FCI instruments are validated for compatibility.

Direct peers

  • Asico: US manufacturer of ophthalmic microsurgical instruments including forceps, scissors, and speculums used in cataract and vitreoretinal surgery. Comparable to FCI on reusable and single-use surgical instrument portfolios sold directly to ophthalmic surgeons.
  • Geuder AG: German manufacturer of ophthalmic surgical instruments, devices, and consumables including vitreoretinal and glaucoma equipment. Comparable to FCI as a European specialist serving cataract, vitreoretinal, and glaucoma surgeons with proprietary and distributed instruments.
  • Moria: France-based specialist in ophthalmic surgical instruments, knives, and micro-surgical devices. Highly comparable as a French-headquartered, niche-focused ophthalmic surgical instrument and device manufacturer with overlapping categories in cataract, cornea, and oculoplastics.
  • Rumex International: US-based manufacturer of ophthalmic surgical instruments including forceps, scissors, needle holders, and speculums. Comparable to FCI on reusable stainless-steel ophthalmic instruments and global distribution to cataract and vitreoretinal surgeons.
  • Katena Products: US ophthalmic surgical products company offering instruments, IOLs, and consumables used in cataract, glaucoma, and oculoplastic surgery. Comparable to FCI as a multi-category ophthalmic surgical device and instrument supplier to hospital and ambulatory surgery centers.
  • Beaver-Visitec International (BVI): US-based manufacturer of single-use ophthalmic surgical instruments, blades, and cannulas. Comparable to FCI on single-use ophthalmic disposables, microsurgical instruments, and hospital-direct sales motion across cataract and vitreoretinal procedures.
  • MicroSurgical Technology (MST): US-based ophthalmic surgical device company producing micro-incision instruments and specialty devices for cataract, vitreoretinal, and glaucoma surgery. Comparable to FCI on micro-incision instrumentation and direct-to-surgeon specialty ophthalmic distribution.
  • Dutch Ophthalmic Research Center (DORC): Dutch ophthalmic device company specializing in vitreoretinal surgery systems, instruments, and tamponades. Directly comparable as a vitreoretinal surgical devices specialist and a fellow ZEISS Medical Technology portfolio company following acquisition.

Emerging players

  • New World Medical: US ophthalmic device company specializing in glaucoma drainage devices (Ahmed, Baerveldt) and surgical implants. Comparable to FCI in the glaucoma implant category where FCI distributes Ahmed valves and its own Implant de Paul.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights6 records

Customer concentration

FCI compliance and trust

Trust signal

Compliance3 records

FCI financial estimates

Financial estimate

Revenue estimate

Valuation estimate

FCI leadership team

Management profile

Number of profiles

FCI subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

FCI funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

FCI M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FCI

What does FCI do?

FCI S.A.S. manufactures, designs, and distributes ophthalmic surgical medical devices and instruments for eye surgery. The portfolio spans seven therapeutic areas — oculoplastics (lacrimal pathways, eyelids, orbit), dry eye (meatal plugs), retina (scleral implants, laser fibers, silicone oil), cataract (intraocular lenses, capsular rings, knives, cannulas), glaucoma (valves, implants), surgical instruments, and veterinary ophthalmology. The company also distributes third-party ophthalmic brands including MORCHER, Katalyst Surgical, PSI, and SHARPOINT.

Is FCI a public or private company?

FCI is a private company. It is classified as corporate owned and is currently operating.

When was FCI founded?

FCI was founded in 1984. It employs 51 to 100 people.

Where is FCI based?

FCI is headquartered in Paris, France, in the Europe region.

How does FCI make money?

Two revenue lines are on record. Medical device sales are the primary driver. The others are distributed products.

Who are FCI's main competitors?

Alcon is listed as a broad incumbent. Direct peers are Asico, Geuder AG, Moria, Rumex International, Katena Products, Beaver-Visitec International (BVI), MicroSurgical Technology (MST) and Dutch Ophthalmic Research Center (DORC). New World Medical is listed as an emerging player.

Does FCI have an API?

No public API is recorded for FCI.

What industry is FCI in?

FCI's product category is Ophthalmic Medical Devices. Its primary akta.pro industry code is HLAHAJAH, Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics), with a secondary code of HLAHAJAL, Oculoplastics & Lacrimal Surgical Devices (Ptosis/Orbital Tools, DCR/Lacrimal Stents, Facial Implants). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The Times of IndiaMSME drives SC/ST entrepreneur outreach, vendor linkages in city | Chandigarh News - The Times of IndiaThe MSME ministry organized an outreach programme in Chandigarh on Monday that was attended by over 100 entrepreneurs from Scheduled Caste and Scheduled Tribe communities, aimed at linking them with government buyers and financial institutions. The event, held at CII Northern Region headquarters in association with the Dalit Indian Chamber of Commerce and Industry, highlighted schemes such as the National SC-ST Hub and urged participants to register on the Udyam portal for scheme eligibility. Representatives from CPSEs, banks, and institutions including Powergrid, FCI, Exim Bank, GeM, IIT Ropar, SBI, and Punjab National Bank provided guidance on vendor empanelment and funding avenues.BusinessGhanaAfreximbank and FCI to host Africa Regional Conference on Factoring, Receivables Finance & Credit...African Export-Import Bank (Afreximbank) and FCI announced they will jointly host the Africa Regional Conference on Factoring, Receivables Finance & Credit Insurance on 15–16 April 2026 in Kampala, Uganda, bringing together financial institutions, development finance institutions, insurers, regulators, and government bodies from across Africa. The conference aims to address Africa's trade finance gap and accelerate intra-African trade volumes under the AfCFTA framework by promoting factoring and supply chain finance as alternative financing tools for SMEs. Registration is currently open, with discussions scheduled on market development, legal frameworks, credit insurance, and digitalisation of receivables finance solutions.Cyprus MailEllinas Finance joins global factoring network FCIEllinas Finance Public Company Ltd, listed on the Cyprus Stock Exchange, announced its admission as an affiliate member of FCI, an international network for factoring and trade receivables finance. The membership grants access to FCI's established framework and correspondent network, enhancing the company's ability to support cross-border factoring transactions. This development is expected to strengthen Ellinas Finance's export factoring offering and facilitate structured trade finance solutions for Cypriot businesses engaged in international trade.The Times of IndiaBig relief for Punjab's farmers as Centre has agreed to shift border fence closer to IB: CM MannPunjab Chief Minister Bhagwant Mann secured an in-principle agreement from Union Home Minister Amit Shah to shift the border security fence closer to the India-Pakistan International Border, enabling thousands of farmers to access farmland that has been trapped beyond the fencing along the 532-km border. The CM also raised multiple long-pending concerns including opposition to the Seeds Bill 2025, rejection of the Sutlej Yamuna Link canal construction, slow foodgrain movement by FCI, a frozen Arthia commission since 2019-20, and non-payment of statutory rural development and Mandi Fund dues to Punjab.RuralvoiceCentre reduces FCI rice rate to Rs 2,250 for states and ethanol producers, lower than Paddy MSPThe Indian central government has reduced the reserve price of FCI rice for states and ethanol producers to Rs 2,250 per quintal to promote sales and ethanol production. The policy revision, effective until June 2025, aims to support food security and meet ethanol blending targets, with a focus on utilizing older rice stocks.ChinimandiGovernment reduces price of FCI rice for distilleries producing ethanol to Rs 2,250 per quintalThe Indian government has reduced the price of FCI rice sold to distilleries for ethanol production from Rs 2,800 to Rs 2,250 per quintal for the year 2024-25 under the OMSS(D) policy. This adjustment aims to incentivize ethanol production, with the sale limited to distilleries registered with Oil Marketing Companies and involving a total quota of 24 LMT.